The Role of Personality in the Course of Health-related Quality of Life and Disease-specific Health Status Among Colorectal Cancer Survivors: A Prospective Population-based Study from the PROFILES Registry
Overview
Affiliations
Background: Prospective studies in various cardiovascular populations show that Type D personality predicted impaired health-related quality of life (HRQoL) and disease-specific health status. We examined the effect of negative affectivity (NA), social inhibition (SI) and their combined effect (Type D personality) on HRQoL and disease-specific health status among colorectal cancer (CRC) patients.
Methods: CRC patients diagnosed between 2000 and 2009, as registered in the Dutch population-based Eindhoven Cancer Registry, received questionnaires on Type D personality (DS14), HRQoL (EORTC QLQ-C30) and disease-specific health status (EORTC QLQ-CR38) in 2010, 2011 and 2012.
Results: Response rates were 73% (n = 2625), 83% (n = 1643) and 82% (n = 1458), respectively. Analyses were done on those completing at least two questionnaires (n = 1735). Individuals with Type D (NA+/SI+; 19%) and high NA (NA+/SI-; 11%) reported a significantly worse HRQoL and disease-specific health status compared to NA-/SI+ and NA-/SI-. Differences were stable over time. Linear mixed effects models showed that Type Ds had a lower quality of life, cognitive and emotional functioning, more insomnia, diarrhea, gastrointestinal, defecation and stoma-related problems and poor body image and future perspective compared to the reference group (NA-/SI-), even after controlling for sociodemographic and clinical variables. High NA individuals (NA+/SI-) reported similar poor health outcomes as Type Ds. However, they also reported lower social functioning and more fatigue, pain, micturition- and financial problems, while Type Ds reported more constipation, sexual problems and less sexual enjoyment.
Conclusions: Type D personality and high NA both have a significant negative stable impact on HRQoL and disease-specific health status among CRC patients.
Zhao Y, Xu Y, Wang T, Hua M, Baral S, Sun Q Asia Pac J Oncol Nurs. 2024; 11(12):100617.
PMID: 39687667 PMC: 11647483. DOI: 10.1016/j.apjon.2024.100617.
Dahl A, Smeland K, Eikeland S, Fagerli U, Bersvendsen H, Fossa A Acta Oncol. 2024; 63:600-606.
PMID: 39099321 PMC: 11332479. DOI: 10.2340/1651-226X.2024.40312.
Prevention of malignant digestive system tumors should focus on the control of chronic inflammation.
Zhang Y, Chen X, Wang Y, Hou Y, Zhang Y, Wang K World J Gastrointest Oncol. 2023; 15(3):389-404.
PMID: 37009320 PMC: 10052658. DOI: 10.4251/wjgo.v15.i3.389.
Type D Personality and Health Behaviors in People Living with Obesity.
Buczkowska M, Gorski M, Domagalska J, Buczkowski K, Nowak P Int J Environ Res Public Health. 2022; 19(22).
PMID: 36429364 PMC: 9690440. DOI: 10.3390/ijerph192214650.
Grassi L, Caruso R, Belvederi Murri M, Fielding R, Lam W, Sabato S Clin Pract Epidemiol Ment Health. 2022; 17(1):271-279.
PMID: 35444709 PMC: 8985468. DOI: 10.2174/1745017902117010271.